medigraphic.com
ESPAÑOL

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 5

<< Previous number Next number >>

September-October, 2014; Volume 13: Number 5
Ann Hepatol 2014; 13 (5)


Contents


Hepatology Highlights

FULL TEXT FLIPBOOK

Hepatology highlights


Bedogni, Giorgio; Tiribelli, Claudio

Concise reviews

FULL TEXT FLIPBOOK

Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients


Caroline Buss; Cristiane Valle-Tovo; Suellen Miozzo; Alves de Mattos, Angelo

FULL TEXT FLIPBOOK

Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease


Zhang Wenfeng; Wu, Yakun; Mu Di; Gong, Jianping; Wu Chuanxin; Huang Chun

Original articles

FULL TEXT FLIPBOOK

Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina


María S Munné; Nancy R Altabert; Lucio O Otegui M; Sara N Vladimirsky; Rita Moreiro; María P Espul; Carlos Espul; Abelardo Manzur; Sonia S Soto; Leonardo S Brajterman; Jorge E González

FULL TEXT FLIPBOOK

Treatment of chronic hepatitis C genotype 1 early responders with 36 week pegylated interferon and ribavirin therapy


Ajit Sood; Vandana Midha; Omesh Goyal

FULL TEXT FLIPBOOK

Hepatitis E virus exposure in pregnant women in rural Durango, Mexico


Cosme Alvarado-Esquivel; Luis F Sánchez-Anguiano; Hernández-Tinoco, Jesús

FULL TEXT FLIPBOOK

Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?


Abdel-Rahman N Zekri; Ahmed M Raafat; Suzan Elmasry; Abeer A Bahnassy; Yasmin Saad; Hamed A Dabaon; Mohamed El-Kassas; Hend I Shousha; Auhood A Nassar; Mohamed Ale EL-Dosouky; Nehal Hussein

FULL TEXT FLIPBOOK

Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience


Nabiha Faisal; Yoshida, Eric M; Bilodeau, Marc; Wong, Philip; Ma, Mang; Burak, Kelly W; Al-Judaibi, Bandar; Renner, Eberhard L; Leslie B Lilly

FULL TEXT FLIPBOOK

Survey of health status, nutrition and geography of food selection of chronic liver disease patients


Timothy Leslie; Lisa Pawloski; Jillian Kallman-Price; Escheik, Carey; Noreen Hossain; Yun Fang; Lynn H Gerber; Younossi, Zobair M

FULL TEXT FLIPBOOK

Ultra-sensitive procalcitonin may help rule out bacterial infections in patients with cirrhosis


Marciano, Sebastian; Leila Haddad; Alfredo P Martínez; María L Posadas; Piñero, Federico; Gonzalo J Mora; Laura N Guerrero; Ridruejo, Ezequiel; Mandó, Oscar G; Diego H Giunta; Adrián C Gadano

FULL TEXT FLIPBOOK

Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes


Karlyn Martin; Leila Kia; Neehar D Parikh

Images in hepatology

FULL TEXT FLIPBOOK

Embolization of porto-systemic shunt as treatment for recurrent hepatic encephalopathy


Hugh Leonard; James O’Beirne; Dominic Yu; Emmanuel Tsochatzis

Case Reports

FULL TEXT FLIPBOOK

Minimally invasive treatment of Mirizzi’s syndrome: is there a safe way? Report of a case series


Giuseppe Piccinni; Andrea Sciusco; Giuseppe Massimiliano De Luca; Angela Gurrado; Alessandro Pasculli; Mario Testini

FULL TEXT FLIPBOOK

Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir


Vladimir Marquez-Azalgara; Hussaini, Trana; Erb, Siegfried R; Yoshida, Eric M

FULL TEXT FLIPBOOK

Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors


Serena Pelusi; Rametta, Raffaela; Claudia Della Corte; Riccardo Congia; Paola Dongiovanni; Edoardo A Pulixi; Fargion, Silvia; Anna L Fracanzani; Valerio Nobili; Valenti, Luca

Letters to the editor

FULL TEXT FLIPBOOK

Mean platelet volume: a useful predictor of ascitic fluid infection in cirrhotic patients?


Alpaslan Tanoglu; Ergenekon Karagöz

FULL TEXT FLIPBOOK

Mean platelet volume is a useful indicator of systemic inflammation in cirrhotic patients with ascitic fluid infection


Burak Suvak; Serkan Torun; Adnan Tas; Yavuz Beyazit

Liver news elsewhere

FULL TEXT FLIPBOOK

The good, the bad and the ugly of the new treatments for hepatitis C virus


Silva-Vidal, Karen V; Méndez-Sánchez, Nahum

Meeting of the Latin American Association

XXIII Annual Meeting of the Latin American Association for the Study of the Liver and the National Congress of the Mexican Association of Hepatology
September 11-13, 2014. Cancun, Quintana Roo, Mexico
Index Section


XXIII Annual Meeting of the Latin American Association for the Study of the Liver and the National Congress of the Mexican Association of Hepatology
September 11-13, 2014. Cancun, Quintana Roo, Mexico
Oral presentations


XXIII Annual Meeting of the Latin American Association for the Study of the Liver and the National Congress of the Mexican Association of Hepatology
September 11-13, 2014. Cancun, Quintana Roo, Mexico
Poster Presentations





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2014;13